New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

Colon cancer is on the rise in younger people, which is why testing guidelines recommend testing starting at 45 for those at average risk. To stop colon cancer, it’s important to know when and how to ...

Individuals with two HNPCC-associated cancers a including synchronous and metachronous colorectal cancers or associated extracolonic cancers Individuals with colorectal cancer and a first-degree ...

Performing genetic testing in every patient diagnosed with colon cancer, and not just those considered high-risk, could identify that person's risk of developing another cancer later in life. Germline ...

Fecal occult blood testing, a patient-administered test that is much less expensive than a colonoscopy, is a valid option for early detection of colon cancer, according to a report in the Canadian ...

This article is brought to you by Blue Cross and Blue Shield of Louisiana. Colon cancer has become more predominant across the nation in recent years, with the American Cancer Society estimating that ...

(Reuters Health) - People may be more likely to get colorectal cancer screenings when doctors let them choose what type of test to have, a U.S. study suggests. Researchers focused on two widely used ...

Data support routine use of circulating tumor DNA testing in management of stage III colon cancer patients Tumor fraction analysis provides further insights for patient management in patients with ...

As moms, we're constantly vigilant about our family's health, but there's a concerning trend that deserves our attention: colon cancer rates are surging among younger adults ( that's you and me, ...

Researchers at the University of California, Irvine have developed a 3D human colon model integrated with bioelectronics to aid in colorectal cancer research and drug discovery. The "3D in vivo ...